Provided by Tiger Trade Technology Pte. Ltd.

Cue Biopharma, Inc.

0.4859
-0.0424-8.03%
Volume:469.17K
Turnover:238.35K
Market Cap:38.26M
PE:-1.11
High:0.5399
Open:0.5239
Low:0.4810
Close:0.5283
52wk High:1.75
52wk Low:0.4810
Shares:78.74M
Float Shares:78.47M
Volume Ratio:2.78
T/O Rate:0.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4366
EPS(LYR):-0.7221
ROE:-195.19%
ROA:-62.31%
PB:2.89
PE(LYR):-0.67

Loading ...

Cue Biopharma Chief Medical Officer Matteo Levisetti to Depart

Reuters
·
Nov 21

Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors

Reuters
·
Nov 20

BRIEF-Immunoscape Signs Deal With Cue Biopharma To Develop Solid Tumor Cancer Treatment

Reuters
·
Nov 14

Immunoscape: Entered in-Licensing Deal With Cue Biopharma for Development of New Class of Therapies to Attack Solid Tumor Cancers

THOMSON REUTERS
·
Nov 14

Cue Biopharma Licenses Immuno-STAT® Oncology Technology to ImmunoScape

Reuters
·
Nov 14

Cue Biopharma Q3 collaboration revenue falls

Reuters
·
Nov 13

Cue Biopharma Q3 EPS $(0.07) Beats $(0.09) Estimate, Sales $2.149M Miss $2.290M Estimate

Benzinga
·
Nov 13

Cue Biopharma Names Usman Azam President and CEO

Reuters
·
Nov 13

Cue Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights

THOMSON REUTERS
·
Nov 13

BRIEF-Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors

Reuters
·
Nov 06

Cue Biopharma Inc. Files Initial Statement of Beneficial Ownership for CEO and Director Usman Azam

Reuters
·
Oct 03

BRIEF-Cue Biopharma Appoints New CEO, Shifts Focus to Autoimmune Therapies

Reuters
·
Sep 29

Cue Biopharma Appoints Usman Azam as CEO, Shifts Focus to Autoimmune Therapies as Daniel Passeri Becomes Strategic Advisor

Reuters
·
Sep 29

Cue Biopharma Announces Strategic Transition in Leadership to Further Enable Next Stage of Growth With Disruptive Autoimmune Therapeutic Candidates

THOMSON REUTERS
·
Sep 29

Cue Biopharma Inc - Usman Azam Appointed CEO of Cue Biopharma

THOMSON REUTERS
·
Sep 29

Cue Biopharma Inc - Daniel Passeri Transitions to Strategic Advisor at Co

THOMSON REUTERS
·
Sep 29

Wu Xiangdong References Hot Topics During Live Stream: Nearly Mistook Restaurant Industry Leader for Jia Guolong

Deep News
·
Sep 19

Cue Biopharma Initiated at Buy by LUCID CAPITAL MARKETS

Dow Jones
·
Aug 26

Cue Biopharma Inc. to Participate in Fireside Chat at Cantor Global Healthcare Conference

Reuters
·
Aug 21

Cue Biopharma Announces Initiation of Investigator Sponsored Trial of CUE-102 in Recurrent Glioblastoma Multiforme

GlobeNewswire
·
Aug 13